financetom
Business
financetom
/
Business
/
Cboe Global Markets' Q3 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cboe Global Markets' Q3 Adjusted Earnings, Revenue Increase
Nov 1, 2024 5:17 AM

07:50 AM EDT, 11/01/2024 (MT Newswires) -- Cboe Global Markets ( CBOE ) reported Q3 adjusted earnings Friday of $2.22 per diluted share, up from $2.06 a year earlier.

Analysts polled by Capital IQ expected $2.19.

Total revenue less cost of revenue for the quarter ended Sept. 30 was $532 million, compared with $480.5 million a year earlier.

Analysts surveyed by Capital IQ expected $531.4 million.

Price: 209.95, Change: +0.33, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Mar 19, 2024
ZURICH (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian...
Gucci's steep sales decline throws spotlight on China
Gucci's steep sales decline throws spotlight on China
Mar 20, 2024
By Mimosa Spencer PARIS (Reuters) - Shares of Kering are expected to open down on Wednesday, after the company warned first quarter sales at its star label Gucci would drop by around 20% due to weakness in Asia. The warning underscores the challenge Kering faces as it seeks to reignite sales momentum at Gucci, which accounts for half of group...
Lonza to buy biologics site from Roche in US for $1.2 bln
Lonza to buy biologics site from Roche in US for $1.2 bln
Mar 19, 2024
ZURICH, March 20 (Reuters) - Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.3 million) to upgrade the facility and enhance capabilities at the site to accommodate the next...
Billionaire Mathieson ups stake in Australian casino operator Star Entertainment
Billionaire Mathieson ups stake in Australian casino operator Star Entertainment
Mar 19, 2024
(Reuters) - A firm owned by Australian billionaire Bruce Mathieson has increased its stake in casino operator Star Entertainment to 8.21% from 6%, an exchange filing showed on Wednesday. Following the stake increase, Mathieson's Investment Holdings Pty is the largest shareholder in the casino operator. The development comes at a time when Star Entertainment is facing a second inquiry into...
Copyright 2023-2026 - www.financetom.com All Rights Reserved